Table 4.

Multivariate analysis examining the association between anti-KIF20B positivity and cranial neuropathy within 5 years of follow-up

Covariates*	Cranial neuropathy positivity OR (95% CI)
Anti-KIF20B+ at baseline	5.2 (1.4 to 19.1)
Age at baseline	1.0 (0.9 to 1.1)
Female	0.6 (0.1 to 2.5)
White race and ethnicity	1.4 (0.4 to 5.1)
Haematological disorder	3.0 (0.5 to 17.1)
ANA	1.2 (0.1 to 21.0)

Bold indicates statistically significant result.

*Model covariates include anti-KIF20B positivity, adjusting for age at baseline (enrolment or first follow-up visit), female, White race and ethnicity, and significantly different clinical characteristics at baseline.

KIF20B, kinesin family member 20B.